Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1988 Jul;32(7):1078–1079. doi: 10.1128/aac.32.7.1078

In vitro susceptibilities of Nocardia species to newer antimicrobial agents.

P Berkey 1, D Moore 1, K Rolston 1
PMCID: PMC172347  PMID: 3190193

Abstract

The in vitro activities of various quinolones, two newer cephalosporins, and imipenem against 23 strains of Nocardia asteroides, 4 strains of Nocardia brasiliensis, and 4 strains of Nocardia caviae were determined by an agar dilution method. PD-117558, a newer carboxyquinolone, and imipenem were the most active agents tested, inhibiting 90% of N. asteroides isolates at an MIC of 2 micrograms/ml. Of the 23 strains of N. asteroides, 15 were susceptible to cefpirome and 10 were susceptible to ciprofloxacin. The N. brasiliensis and N. caviae strains were very susceptible to PD-117558 (MIC, less than or equal to 1 microgram/ml), moderately susceptible to ciprofloxacin, and resistant to most of the other tested drugs.

Full text

PDF
1078

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arroyo J. C., Nichols S., Carroll G. F. Disseminated Nocardia caviae infection. Am J Med. 1977 Mar;62(3):409–412. doi: 10.1016/0002-9343(77)90839-7. [DOI] [PubMed] [Google Scholar]
  2. Auckenthaler R., Michéa-Hamzehpour M., Pechère J. C. In-vitro activity of newer quinolones against aerobic bacteria. J Antimicrob Chemother. 1986 Apr;17 (Suppl B):29–39. doi: 10.1093/jac/17.suppl_b.29. [DOI] [PubMed] [Google Scholar]
  3. Beaman B. L., Burnside J., Edwards B., Causey W. Nocardial infections in the United States, 1972-1974. J Infect Dis. 1976 Sep;134(3):286–289. doi: 10.1093/infdis/134.3.286. [DOI] [PubMed] [Google Scholar]
  4. Dewsnup D. H., Wright D. N. In vitro susceptibility of Nocardia asteroides to 25 antimicrobial agents. Antimicrob Agents Chemother. 1984 Feb;25(2):165–167. doi: 10.1128/aac.25.2.165. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Gombert M. E., Aulicino T. M., duBouchet L., Berkowitz L. R. Susceptibility of Nocardia asteroides to new quinolones and beta-lactams. Antimicrob Agents Chemother. 1987 Dec;31(12):2013–2014. doi: 10.1128/aac.31.12.2013. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Gombert M. E. Susceptibility of Nocardia asteroides to various antibiotics, including newer beta-lactams, trimethoprim-sulfamethoxazole, amikacin, and N-formimidoyl thienamycin. Antimicrob Agents Chemother. 1982 Jun;21(6):1011–1012. doi: 10.1128/aac.21.6.1011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Gutmann L., Goldstein F. W., Kitzis M. D., Hautefort B., Darmon C., Acar J. F. Susceptibility of Nocardia asteroides to 46 antibiotics, including 22 beta-lactams. Antimicrob Agents Chemother. 1983 Feb;23(2):248–251. doi: 10.1128/aac.23.2.248. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Smego R. A., Jr, Gallis H. A. The clinical spectrum of Nocardia brasiliensis infection in the United States. Rev Infect Dis. 1984 Mar-Apr;6(2):164–180. doi: 10.1093/clinids/6.2.164. [DOI] [PubMed] [Google Scholar]
  9. Smego R. A., Jr, Moeller M. B., Gallis H. A. Trimethoprim-sulfamethoxazole therapy for Nocardia infections. Arch Intern Med. 1983 Apr;143(4):711–718. [PubMed] [Google Scholar]
  10. Young L. S., Armstrong D., Blevins A., Lieberman P. Nocardia asteroides infection complicating neoplastic disease. Am J Med. 1971 Mar;50(3):356–367. doi: 10.1016/0002-9343(71)90224-5. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES